Michael H. Woo

985 total citations
20 papers, 755 citations indexed

About

Michael H. Woo is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael H. Woo has authored 20 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael H. Woo's work include Cancer therapeutics and mechanisms (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Michael H. Woo is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Michael H. Woo collaborates with scholars based in United States, Belgium and Japan. Michael H. Woo's co-authors include Mary V. Relling, Howard L. McLeod, Margaret Kindlen, Mary‐Ann Bjornsti, Ching‐Hon Pui, Pramodini Kale-Pradhan, L J Hak, M Storm, Gaston K. Rivera and William E. Evans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Michael H. Woo

20 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael H. Woo United States	18	272	269	246	182	75	20	755
Torben Stamm Mikkelsen Denmark	13	336 1.2×	251 0.9×	343 1.4×	388 2.1×	125 1.7×	37	1.1k
C. L. Szumlanski United States	9	403 1.5×	321 1.2×	196 0.8×	146 0.8×	115 1.5×	13	864
Kjeld Schmiegelow Denmark	7	449 1.7×	186 0.7×	317 1.3×	116 0.6×	190 2.5×	8	829
Rebecca L. Roberts New Zealand	18	337 1.2×	203 0.8×	117 0.5×	74 0.4×	145 1.9×	26	945
Raffaella Franca Italy	15	200 0.7×	273 1.0×	120 0.5×	99 0.5×	31 0.4×	45	697
Ryan S. Funk United States	14	77 0.3×	286 1.1×	107 0.4×	113 0.6×	82 1.1×	43	782
Delphine Marez France	13	253 0.9×	263 1.0×	176 0.7×	222 1.2×	446 5.9×	15	857
Leslie A. Kenna United States	9	85 0.3×	169 0.6×	72 0.3×	119 0.7×	66 0.9×	9	640
Kaori Narahara Japan	10	60 0.2×	201 0.7×	101 0.4×	182 1.0×	293 3.9×	11	568
Justin Earp United States	17	40 0.1×	231 0.9×	146 0.6×	151 0.8×	156 2.1×	36	829

Countries citing papers authored by Michael H. Woo

Since Specialization

Citations

This map shows the geographic impact of Michael H. Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Woo more than expected).

Fields of papers citing papers by Michael H. Woo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Woo. The network helps show where Michael H. Woo may publish in the future.

Co-authorship network of co-authors of Michael H. Woo

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Woo. A scholar is included among the top collaborators of Michael H. Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Woo. Michael H. Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bröker, Linda E., Filip De Vos, Cees J. van Groeningen, et al.. (2006). Phase I Trial with BMS-275183, a Novel Oral Taxane with Promising Antitumor Activity. Clinical Cancer Research. 12(6). 1760–1767. 19 indexed citations

Waardenburg, Robert C.A.M. van, Robert J. D. Reid, Michael H. Woo, et al.. (2005). Defects in SUMO (Small Ubiquitin-related Modifier) Conjugation and Deconjugation Alter Cell Sensitivity to DNA Topoisomerase I-induced DNA Damage. Journal of Biological Chemistry. 280(25). 23566–23575. 44 indexed citations

Woo, Michael H., Jennifer K. Peterson, Catherine A. Billups, et al.. (2004). Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models. Cancer Chemotherapy and Pharmacology. 55(5). 411–419. 18 indexed citations

Woo, Michael H., et al.. (2003). Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality. Proceedings of the National Academy of Sciences. 100(24). 13767–13772. 36 indexed citations

Relling, Mary V., M Storm, Michael H. Woo, et al.. (2003). Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia. 17(8). 1583–1588. 100 indexed citations

Woo, Michael H., et al.. (2003). Studying DNA Topoisomerase I-Targeted Drugs In the Yeast: Saccharomyces cerevisiae. Humana Press eBooks. 95. 303–314. 5 indexed citations

Woo, Michael H., et al.. (2002). Active Site Mutations in DNA Topoisomerase I Distinguish the Cytotoxic Activities of Camptothecin and the Indolocarbazole, Rebeccamycin. Journal of Biological Chemistry. 277(6). 3813–3822. 31 indexed citations

Kindlen, Margaret, Michael H. Woo, & Howard L. McLeod. (2002). Genetic basis of drug metabolism. American Journal of Health-System Pharmacy. 59(21). 2061–2069. 95 indexed citations

Leggas, Markos, Clinton F. Stewart, Michael H. Woo, et al.. (2002). Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.. PubMed. 8(9). 3000–7. 25 indexed citations

10.

Hak, L J, et al.. (2000). ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia. Journal of Immunological Methods. 239(1-2). 75–83. 23 indexed citations

11.

Woo, Michael H., Lawrence J. Hak, Michael C. Storm, et al.. (2000). Hypersensitivity or Development of Antibodies to Asparaginase Does Not Impact Treatment Outcome of Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 18(7). 1525–1532. 141 indexed citations

12.

Cai, Xiangjun, Michael H. Woo, Mathew J. Edick, & Mary V. Relling. (1999). Simultaneous quantitation of etoposide and its catechol metabolite in human plasma using high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 728(2). 241–250. 31 indexed citations

13.

Woo, Michael H., Mary V. Relling, Daryl Sonnichsen, et al.. (1999). Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias.. PubMed. 5(3). 543–9. 31 indexed citations

14.

Woo, Michael H., et al.. (1999). Pharmacokinetics of paclitaxel in an anephric patient. Cancer Chemotherapy and Pharmacology. 43(1). 92–96. 21 indexed citations

15.

Woo, Michael H., Lawrence J. Hak, Michael C. Storm, et al.. (1999). Cerebrospinal Fluid Asparagine Concentrations After Escherichia coli Asparaginase in Children With Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 17(5). 1568–1568. 31 indexed citations

16.

Chen, Chun‐Lin, Michael H. Woo, Geoffrey Neale, et al.. (1998). A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 403(1-2). 113–125. 9 indexed citations

17.

Kale-Pradhan, Pramodini & Michael H. Woo. (1997). A Review of the Effects of Plasmapheresis on Drug Clearance. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(4). 684–695. 25 indexed citations

18.

Woo, Michael H. & Pramodini Kale-Pradhan. (1997). Fludrocortisone in the treatment of subarachnoid hemorrhage-induced hyponatremia.. PubMed. 31(5). 637–9. 17 indexed citations

19.

Woo, Michael H., et al.. (1997). Infectious Diseases: Interferon Alfa in the Treatment of Chronic Viral Hepatitis B and C. Annals of Pharmacotherapy. 31(3). 330–337. 31 indexed citations

20.

Woo, Michael H. & Maureen A. Smythe. (1997). Association of SIADH with selective serotonin reuptake inhibitors.. PubMed. 31(1). 108–10. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact